in patients with cvi the active drug gave significant improvements ( p less than 0.01 ) in the measured volume of the foot and lower limb , in clinical tenderness ( p less than 0.05 ) , and in most of the symptoms ( including feelings of heaviness , swelling , tiredness , and aching in the lower extremities ) .
C0016504
foot
C0023216
lower extremities